Genetic origins of anxiety in women: A role for a functional catechol-O-methyltransferase polymorphism

Psychiatric Genetics

Volumn 13, Issue 1, 2003, Pages 33-41

  Enoch, Mary Anne ^a   Xu, Ke ^a   Ferro, Erica ^a   Harris, Claudia R ^a   Goldman, David ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Anxiety; Catechol O methyltransferase; Genes; Low voltage alpha electroencephalogram; Norepinephrine; Tridimensional Personality Questionnaire

Indexed keywords

CATECHOL METHYLTRANSFERASE; DNA;

ADULT; ALCOHOLISM; ALLELE; AMERICAN INDIAN; ANXIETY DISORDER; ARTICLE; BIOLOGICAL TRAIT; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAPHY; FEMALE; GENDER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL;

ANXIETY DISORDERS; AVOIDANCE LEARNING; CATECHOL O-METHYLTRANSFERASE; ELECTROENCEPHALOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; MALE; MARYLAND; OKLAHOMA; RESTRICTION MAPPING; SEX CHARACTERISTICS;

EID: 0037335094     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-200303000-00006     Document Type: Article

References (44)

1. American Psychiatric Association (1987). Diagnostic and statistical manual of mental disorders. 3rd rev. ed. (DSM-III-R). Washington, DC: American Psychiatric Association.
2. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders. 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association.
3. Boudikova B, Szumlanski C, Maidak B, Weinshilboum R (1990). Human liver catechol-O-methyltransferase pharmacogenetics. Clin Pharmacol Ther 48:381-389.
4. Bremner JD, Krystal JH, Southwick SM, Charney DS (1996). Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse 23:28-38.
5. Cloninger CR (1987). A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 44:573-788.
6. Coppola R (1979). Isolating low frequency activity in EEG spectrum analysis. Etectroencephatogr Clin Neurophysiol 46:224-226.
7. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, et al. (2001). Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98:6917-6922.
8. Enoch M-A, Rohrbaugh JW, Davis EZ, Harris CR, Ellingson RJ, Andreason P, et al. (1995). Relationship of genetically transmitted alpha EEG traits to anxiety disorders and alcoholism. Am J Med Genet 60:400-408.
9. Enoch M-A, White K, Harris CR, Robin RW, Ross J, Rohrbaugh JW, Goldman D (1999). Association of Low-Voltage Alpha EEG with a subtype of alcohol use disorders. Alcohol Clin Exp Res 23:1312-1319.
10. Enoch M-A, Greenberg BD, Murphy DL, Goldman D (2001). Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive-compulsive disorder. Biol Psychiatry 49:385-388.
11. Eysenck HJ, Eysenck SBG (1975). Manual of the Eysenck Personality Questionnaire (junior and adult). London: Hodder & Stoughton.
12. Fahndrich E, Coper H, Christ W, Helmchen H, Muller-Oerlinghausen B, Pietzcker A (1980). Erythrocyte COMT-activity in patients with affective disorders. Acta Psychiatr Scand 61:427-437.
13. Floderus Y, Ross SB, Wetterberg L (1981). Erythrocyte catechol-O-methyltransferase activity in a Swedish population. Clin Genet 19:389-392.
14. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M (1998). Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95:9991-9996.
15. Gratacos M, Nadal M, Martin-Santos R, Pujana MA, Gago J, Peral B, et al. (2001). A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell 106:367-379.
16. Grachev ID, Apkarian AV (2000). Chemical mapping of anxiety in the brain of healthy humans: an in vivo 1H-MRS study on the effects of sex, age, and brain region. Hum Brain Map 11:261-272.
17. Horowitz R, Kotler M, Shufman E, Aharoni S, Kremer I, Cohen H, Ebstein RP (2000). Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study. Am J Med Genet 96:599-603.
18. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, Gogos JA (1997). Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA 94:4572-4575.
19. Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P, et al. (1999). Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry 45:1178-1189.
20. Kauhanen J, Hallikainen T, Tuomainen TP, Koulu M, Karvonen MK, Salonen JT, Tiihonen J (2000). Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. Alcohol Clin Exp Res 24:135-139.
21. Lesch PK, Bengel D, Hells A, Sabol SZ, Greenberg BG, Petri S, et al. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
22. Lindgren KA, Larson CL, Schaefer SM, Abercrombie HC, Ward RT, Oakes TR, et al. (1999). Thalamic metabolic rate predicts EEG alpha power in healthy control subjects but not in depressed patients. Biol Psychiatry 45:943-952.
23. Lyoo IK, Lee DW, Kim YS, Kong SW, Kwon JS (2001). Patterns of temperament and character in subjects with obsessive-compulsive disorder. J Clin Psychiatry 62:637-641.
24. Mazzanti CM, Lappalainen J, Long JC, Bengel D, Naukkarinen H, Eggert M, et al. (1998). Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Arch Gen Psychiatry 55:936-940.
25. McCormick DA (1992). Neurotransmitter actions in the thalamus and cerebral cortex. J Clin Neurophysiol 9:212-223.
26. Mynett-Johnson LA, Murphy VE, Claffey E, Shields DC, McKeon P (1998). Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatr Genet 8:221-225.
27. Nutt DJ (2001). Neurobiological mechanisms in generalized anxiety disorder. J Clin Psychiatry 62(suppl 11):22-27, discussion 28.
28. Ohara K, Nagai M, Suzuki Y, Ochiai M, Ohara K (1998). No association between anxiety disorders and catechol-O-methyltransferase polymorphism. Psychiatry Res 80:145-148.
29. Palmatier MA, Kang AM, Kidd KK (1999). Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 46:557-567.
30. Papolos DF, Veit S, Faedda GL, Saito T, Lachman HM (1996). Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catechol-O-methyltransferase allele. Mol Psychiatry 3:346-349.
31. Papolos DF, Faedda GL, Veit S, Goldberg R, Morrow B, Kucherlapati R, Shprintzen RJ (1996). Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 153:1541-1547.
32. Ressler KJ, Nemeroff CB (2001). Role of norepinephrine in the pathophysiology of neuropsychiatric disorders. CNS Spectrums 6:663-670.
33. Richter J, Eisemann M, Richter G (2000). Temperament and character during the course of unipolar depression among inpatients. Eur Arch Psychiatry Clin Neurosci 250:40-47.
34. Sevy S, Papadimitriou GN, Surmount DW, Goldman S, Mendlewicz J (1989). Noradrenergic function in generalized anxiety disorder, major depressive disorder, and healthy subjects. Biol Psychiatry 25:141-152.
35. Spielberger CD, Gorsuch RL, Lushene RD (1970). Test manual for the state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists Press.
36. Starcevic V, Uhlenhuth EH, Fallon S, Pathak D (1996). Personality dimensions in panic disorder and generalized anxiety disorder. J Affect Disord 37: 75-79.
37. Stein MB, Chattier MJ, Lizak MV, Jang KL (2001). Familial aggregation of anxiety-related quantitative traits in generalized social phobia: clues to understanding 'disorder' heritability? Am J Med Genet 105:79-83.
38. Tiihonen J, Hallikainen T, Lachman H, Saito T, Volavka J, Kauhanen J, et al. (1999). Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism. Mol Psychiatry 4:286-289.
39. Van Beijsterveldt CE, Molenaar PC, de Geus EJ, Boomsma D (1996). Heritability of human brain functioning as assessed by electroencephalography. Am J Hum Genet 58:562-573.
40. Vandenbergh DJ, Rodriguez LA, Miller IT, Uhl GR, Lachman HM (1997). High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet 74:439-442.
41. Vogel F (1970). The genetic basis of the normal human electroencephalogram. Humangenetik 10:91-114.
42. Wang T, Franke P, Neidt H, Cichon S, Knapp M, Lichtermann D, et al. (2001). Association study of the low-activity allele of catechol-O-methyltransferase and alcoholism using a family-based approach. Mol Psychiatry 6:109-111.
43. Weinshilboum RM, Otterness DM, Szumlanski CL (1999). Methylation pharmacogenetics: catechol-O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 39:19-52.
44. Xie T, Ho S-L, Ramsden D (1999). Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharm 56:31-38.